143 related articles for article (PubMed ID: 29772444)
1. Functional relevance of SATB1 in immune regulation and tumorigenesis.
Sunkara KP; Gupta G; Hansbro PM; Dua K; Bebawy M
Biomed Pharmacother; 2018 Aug; 104():87-93. PubMed ID: 29772444
[TBL] [Abstract][Full Text] [Related]
2. The Special AT-rich Sequence Binding Protein 1 (SATB1) and its role in solid tumors.
Frömberg A; Engeland K; Aigner A
Cancer Lett; 2018 Mar; 417():96-111. PubMed ID: 29306014
[TBL] [Abstract][Full Text] [Related]
3. The Role of SATB1 in Tumour Progression and Metastasis.
Glatzel-Plucińska N; Piotrowska A; Dzięgiel P; Podhorska-Okołów M
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450715
[TBL] [Abstract][Full Text] [Related]
4. SATB1 is a Novel Molecular Target for Cancer Therapy.
Ding M; Pan J; Guo Z; Liu Q; Yang C; Mao L
Cancer Invest; 2018 Jan; 36(1):28-36. PubMed ID: 29381393
[TBL] [Abstract][Full Text] [Related]
5. SATB1 overexpression regulates the development and progression in bladder cancer through EMT.
Wan F; Cheng C; Wang Z; Xiao X; Zeng H; Xing S; Chen X; Wang J; Li S; Zhang Y; Xiang W; Zhu Z; Johnson C; Zhu Z
PLoS One; 2015; 10(2):e0117518. PubMed ID: 25706386
[TBL] [Abstract][Full Text] [Related]
6. SATB family chromatin organizers as master regulators of tumor progression.
Naik R; Galande S
Oncogene; 2019 Mar; 38(12):1989-2004. PubMed ID: 30413763
[TBL] [Abstract][Full Text] [Related]
7. Wnt/β-catenin signaling regulated SATB1 promotes colorectal cancer tumorigenesis and progression.
Mir R; Pradhan SJ; Patil P; Mulherkar R; Galande S
Oncogene; 2016 Mar; 35(13):1679-91. PubMed ID: 26165840
[TBL] [Abstract][Full Text] [Related]
8. SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis.
Han HJ; Russo J; Kohwi Y; Kohwi-Shigematsu T
Nature; 2008 Mar; 452(7184):187-93. PubMed ID: 18337816
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of SATB1 promotes tumor growth and metastasis in liver cancer.
Tu W; Luo M; Wang Z; Yan W; Xia Y; Deng H; He J; Han P; Tian D
Liver Int; 2012 Aug; 32(7):1064-78. PubMed ID: 22583549
[TBL] [Abstract][Full Text] [Related]
10. Analysis of cellular and molecular antitumor effects upon inhibition of SATB1 in glioblastoma cells.
Frömberg A; Rabe M; Oppermann H; Gaunitz F; Aigner A
BMC Cancer; 2017 Jan; 17(1):3. PubMed ID: 28049521
[TBL] [Abstract][Full Text] [Related]
11. SATB1 plays an oncogenic role in esophageal cancer by up-regulation of FN1 and PDGFRB.
Song G; Liu K; Yang X; Mu B; Yang J; He L; Hu X; Li Q; Zhao Y; Cai X; Feng G
Oncotarget; 2017 Mar; 8(11):17771-17784. PubMed ID: 28147311
[TBL] [Abstract][Full Text] [Related]
12. Chromatin organizer SATB1 as a novel molecular target for cancer therapy.
Mir R; Pradhan SJ; Galande S
Curr Drug Targets; 2012 Dec; 13(13):1603-15. PubMed ID: 22998183
[TBL] [Abstract][Full Text] [Related]
13. Multiple effects of the special AT-rich binding protein 1 (SATB1) in colon carcinoma.
Frömberg A; Rabe M; Aigner A
Int J Cancer; 2014 Dec; 135(11):2537-46. PubMed ID: 24729451
[TBL] [Abstract][Full Text] [Related]
14. SATB1 promotes prostate cancer metastasis by the regulation of epithelial-mesenchymal transition.
Mao LJ; Yang CH; Fan L; Gao P; Yang DR; Xue BX; Zheng JN; Shan YX
Biomed Pharmacother; 2016 Apr; 79():1-8. PubMed ID: 27044805
[TBL] [Abstract][Full Text] [Related]
15. Identification of special AT-rich sequence binding protein 1 as a novel tumor antigen recognized by CD8+ T cells: implication for cancer immunotherapy.
Wang M; Yin B; Matsueda S; Deng L; Li Y; Zhao W; Zou J; Li Q; Loo C; Wang RF; Wang HY
PLoS One; 2013; 8(2):e56730. PubMed ID: 23437226
[TBL] [Abstract][Full Text] [Related]
16. Satb1 Overexpression Drives Tumor-Promoting Activities in Cancer-Associated Dendritic Cells.
Tesone AJ; Rutkowski MR; Brencicova E; Svoronos N; Perales-Puchalt A; Stephen TL; Allegrezza MJ; Payne KK; Nguyen JM; Wickramasinghe J; Tchou J; Borowsky ME; Rabinovich GA; Kossenkov AV; Conejo-Garcia JR
Cell Rep; 2016 Feb; 14(7):1774-1786. PubMed ID: 26876172
[TBL] [Abstract][Full Text] [Related]
17. SATB1 and SATB2 play opposing roles in c-Myc expression and progression of colorectal cancer.
Mansour MA; Hyodo T; Akter KA; Kokuryo T; Uehara K; Nagino M; Senga T
Oncotarget; 2016 Jan; 7(4):4993-5006. PubMed ID: 26701851
[TBL] [Abstract][Full Text] [Related]
18. Loss of special AT-rich binding protein 1 expression is a marker of poor survival in lung cancer.
Selinger CI; Cooper WA; Al-Sohaily S; Mladenova DN; Pangon L; Kennedy CW; McCaughan BC; Stirzaker C; Kohonen-Corish MR
J Thorac Oncol; 2011 Jul; 6(7):1179-89. PubMed ID: 21597389
[TBL] [Abstract][Full Text] [Related]
19. Is SATB1 a master regulator in breast cancer growth and metastasis?
Zheng J
Womens Health (Lond); 2008 Jul; 4(4):329-32. PubMed ID: 19072498
[TBL] [Abstract][Full Text] [Related]
20. SATB1 Promotes Pancreatic Cancer Growth and Invasion Depending on MYC Activation.
Chen Z; Li Z; Li W; Zong Y; Zhu Y; Miao Y; Xu Z
Dig Dis Sci; 2015 Nov; 60(11):3304-17. PubMed ID: 26108419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
